Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Analysis of Patients at Risk for Breast Cancer-Related Lymphedema (BCRL) Using Indocyanine Green (ICG) Fluoroscopy and SPYTM Angiography

NCT06672224 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06672224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06672224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Analysis of Patients at Risk for Breast Cancer-Related Lymphedema (BCRL) Using Indocyanine Green (ICG) Fluoroscopy and SPYTM Angiography
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Withdrawn
Start date
August 14, 2025
Completion date
August 14, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer-related lymphedema, breast carcinoma